4th Annual MCLE-a-thon: Federal Funding & Legal Landmines: A Guide for In‑House Teams
As part of the firm’s 4th annual MCLE‑a‑thon, Lance D. Smemoe provides a practical overview of the intellectual property risks associated with federal funding and government contracts. Lance discusses how...
Federal Circuit Review | March 2026
March Federal Circuit Newsletter (Japanese) March Federal Circuit Newsletter (Chinese) Software Claims Failed Alice Step One Where Purported Improvements Were Not Claimed In Trustees Of Columbia University v. Gen Digital...
Federal Circuit Confirms Patent Eligibility of Gene Therapy Patent in Regenexbio Inc. v. Sarepta Therapeutics
Key Takeaway: Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in nature. In REGENXBIO Inc. v....
Subscribe for News and Updates
